Skip to content
Homepage
Author:
Zenas BioPharma
Posted Date:
August 18, 2026
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zenas BioPharma
August 18, 2026
Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Zenas BioPharma
August 13, 2026